Treatment variables during followup.
| Variables | All Patients, n = 125 |
|---|---|
| Hydroxychloroquine, ≥ 3 mos | |
| Current user | 55 (44.0) |
| Ever user | 14 (11.2) |
| Other immunosuppressants*, ≥ 3 mos | |
| Current user | 29 (23.2) |
| Ever user | 17 (13.6) |
| Oral glucocorticoids ≥ 3 mos | |
| Current user | 86 (68.8) |
| Ever user | 7 (5.6) |
| User of ≥ 7.5 mg for ≥ 3 mos | 52 (41.6) |
| Cumulative dose#, g | 9.6 ± 4.3 |
| Cumulative duration of use#, mos | 55.2 ± 10.3 |
| Intravenous methylprednisolone | |
| Ever user | 6 (4.8) |
| Antiosteoporosis therapies | |
| Bisphosphonates | |
| Current user | 17 (13.6) |
| Ever user | 19 (15.2) |
| Use for ≥ 24 mos | 20 (16) |
| Hormone replacement therapy, ≥ 24 mos | |
| Current user | 1 (0.8) |
| Ever user | 1 (0.8) |
| Calcium supplement | |
| Current user | 89 (71.2) |
| Ever user | 10 (8) |
| Vitamin D supplement | |
| Current user | 78 (62.4) |
| Ever user | 8 (6.4) |